Premium
Estrella Immunopharma Inc (ESLA)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Fin d'année 30 Juin 2024 | 2021 | 2022 | 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Return on Assets (%) | -1.083 | -3.587 | -103.146 |
| Return on Equity (%) | 49.304 | 61.067 | -725.037 |
| Return on Invested Capital (%) | 49.454 | 89.856 | -878.11 |
| Operating Margin (%) | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A |
| Book Value Per Share | 7.552 | 3.035 | 0.115 |
| Earnings Per Share | -0.042 | -0.427 | -0.196 |
| Cash Per Share | 0.082 | 0.018 | 0.112 |
| Working Capital Per Share | 0.093 | -0.438 | 0.115 |
| Operating Profit Per Share | N/A | N/A | N/A |
| EBIT Per Share | -0.042 | -0.393 | -0.196 |
| EBITDA Per Share | -0.042 | -0.393 | -0.196 |
| Free Cash Flow Per Share | -0.042 | -0.427 | -0.196 |
| Fin d'année 30 Juin 2024 | 2021 | 2022 | 2024 |
|---|---|---|---|
| Current Ratio | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A |
| Actions en circulation | 1,42M | 1,42M | N/A |
| Fin d'année 30 Juin 2024 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
|---|---|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | ||||||
| Actions en circulation | 1,42M | 1,42M | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capitalisation boursière | 41,97M |
| Ratio cours/bénéfice | -5,74 |
| Ratio prix/ventes | 0 |
| Ratio prix/liquidités | 10,08 |
| Ratio prix/valeur comptable | 9,82 |
| Rendement de dividende | - |
| Actions en circulation | 36,18M |
| Volume moyen (1 semaine) | 6,41k |
| Volume moyen (1 mois) | 16,62k |
| Variation sur 52 semaines | -9,38% |
| Plus haut sur 52 semaines | 3,23 |
| Plus bas sur 52 semaines | 0,63 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
